C
WST icon

Certuity’s West Pharmaceutical WST Stock Holding History

Certuity’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$865K Buy
2,408
+426
+21% +$130K 0.04% 198
2026
Q1 		$497K Buy
1,982
+426
+27% +$106K 0.03% 293
2025
Q4 		$428K Sell
1,556
-90
-5% -$24.6K 0.03% 308
2025
Q3 		$432K Buy
+1,646
New +$400K 0.03% 296
2025
Q1 		– Sell
-816
Closed -$267K – 431
2024
Q4 		$267K Sell
816
-28
-3% -$8.81K 0.03% 281
2024
Q3 		$253K Buy
844
+133
+19% +$40.7K 0.03% 297
2024
Q2 		$234K Sell
711
-33
-4% -$11.7K 0.02% 308
2024
Q1 		$294K Buy
744
+4
+0.5% +$1.48K 0.03% 252
2023
Q4 		$261K Buy
+740
New +$262K 0.03% 270
2021
Q3 		– Sell
-558
Closed -$200K – 414
2021
Q2 		$200K Buy
+558
New +$184K 0.05% 319

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Certuity's WST Position: Q2 2026 in Review

Certuity increased its West Pharmaceutical (WST) stake by 21% in Q2 2026, buying an estimated $130K and bringing the position to 2,408 shares worth $865K. The position accounts for 0.04% of the portfolio, ranked #198.

Certuity first reported a position in WST in Q2 2021 and has held it in 10 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Certuity held 2,408 shares of West Pharmaceutical worth $865K as of Q2 2026.
  • Certuity bought 426 West Pharmaceutical shares in Q2 2026, an estimated $130K.
  • West Pharmaceutical made up 0.04% of Certuity's portfolio in Q2 2026, its #198 holding.
  • Certuity first reported a position in West Pharmaceutical in Q2 2021 and has held it in 10 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.